Kevin Coveney
Director Financiero/CFO en ENVERIC BIOSCIENCES, INC. .
Fortuna: 5 963 $ al 30/04/2024
Origen de la red de primer grado Kevin Coveney.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Other | 10 | |
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA.
3
| Private Company | Biotechnology | 3 |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA.
1
| Holding Company | Biotechnology | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Kevin Coveney a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Epimeron Usa, Inc. | Founder Founder Founder | ||
| WILLOW BIOSCIENCES INC. | Miscellaneous Commercial Services | Chairman Founder Corporate Officer/Principal | |
| University of Calgary | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
ConvaTec, Inc.
 ConvaTec, Inc. Medical SpecialtiesHealth Technology ConvaTec, Inc. engages in the manufacture of medical products and technologies focused on therapies for the management of chronic conditions. It specializes in the wound care, ostomy care, continence and critical care, and infusion devices. The company was founded in 1978 and is headquartered in Bridgewater, NJ. | Medical Specialties | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| University of Toronto | College/University | Undergraduate Degree Doctorate Degree | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
EMI Holding, Inc.
 EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Protarga, Inc. | Chief Executive Officer | ||
| TYME TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Consumer Healthcare Products Association | Director/Board Member | ||
| Sanuthera, Inc. | Director/Board Member | ||
| Welmedix Healthcare Pvt Ltd. | Chief Executive Officer | ||
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Biotechnology | Director of Finance/CFO | |
| IQ EQ (Jersey) Ltd. | Corporate Officer/Principal | ||
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Miami University | College/University | Undergraduate Degree | |
| EMMAUS LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Akshay Wellness, Inc.
 Akshay Wellness, Inc. Pharmaceuticals: OtherHealth Technology Akshay Wellness, Inc. engages in the research, development, and commercialization of holistic health care products. The company was founded by Avani V. Kanubaddi and Sai S. Manickam on March 9, 2005 and is headquartered in Princeton, NJ. | Pharmaceuticals: Other | Chief Executive Officer | |
| INVITAE CORPORATION | Medical/Nursing Services | Director of Finance/CFO | |
SFA Therapeutics, Inc.
 SFA Therapeutics, Inc. Packaged SoftwareTechnology Services SFA Therapeutics, Inc. is a clinical-stage biotech company based on breakthrough research of the human microbiome licensed from Temple University. SFA Therapeutics is located in Jenkintown, PA. Ira Spector has been the CEO of the company since 2017. The company is developing a platform of safer therapeutics focused on the treatment of inflammatory diseases, targeting NF-kB and RAS. SFA has identified six small molecule drug candidates from this platform, including its lead asset, SFA-002, which has shown promising phase 1a results and is currently being investigated in a phase 1b study for psoriasis. The company's research program is focused on the intersection of chronic inflammation and cancer. | Packaged Software | Director of Finance/CFO | |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Biotechnology | Director of Finance/CFO | |
Danforth Advisors LLC
 Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Investment Managers | Corporate Officer/Principal | |
| ANGIOGENEX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NLS PHARMACEUTICS LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
| NEXGEL, INC. | Chemicals: Specialty | President | |
| University of Missouri | College/University | Undergraduate Degree | |
| DRÄGERWERK AG & CO. KGAA | Medical Specialties | Corporate Officer/Principal | |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Biotechnology | Chief Tech/Sci/R&D Officer | |
NGLY1.org
 NGLY1.org Miscellaneous Commercial ServicesCommercial Services NGLY1.org is a non-profit organization dedicated to advancing science in the service of patients, particularly those with NGLY1 deficiency. The organization is based in Salt Lake City, UT. The website provides an overview of Bertrand's life and legacy, including his advocacy for rare disease patients and his contributions to precision medicine. The Bertrand Might Endowment for Hope, a perpetual endowment at the University of Alabama at Birmingham, provides funding for individualized treatments for patients in need. The organization was founded by Matthew Might in honor of his son, Bertrand Might, who lived a remarkable life despite facing a constellation of symptoms from a young age. | Miscellaneous Commercial Services | Founder | |
Q-State Holdings, Inc.
 Q-State Holdings, Inc. BiotechnologyHealth Technology Q-State Holdings, Inc. provides biotechnology services. The company is headquartered in Cambridgem, MA. | Biotechnology | Director/Board Member | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Economic Cycle Research Institute | Chief Executive Officer | ||
Environmental Criminology Research, Inc.
 Environmental Criminology Research, Inc. Packaged SoftwareTechnology Services Environmental Criminology Research, Inc. develops and supplies software for crime analysis to police, military, and security customers. It offers rigel workstation, rigel analyst, Gemini, training, and support. The company was founded by Kim Rossmo and is headquartered in Vancouver, Canada. | Packaged Software | Chief Executive Officer | |
Emergency Care Research Institute
 Emergency Care Research Institute Medical/Nursing ServicesHealth Services Emergency Care Research Institute operates as a non-profit organization that provides publications, information, and consulting services for healthcare technology assessment. Its services include evidence based consulting services, custom product briefs, emerging technology reports, technology forecasts, custom rapid responses, and evidence reports. The company was founded by Joel J. Nobel in 1968 and is headquartered in Plymouth Meeting, PA. | Medical/Nursing Services | Chief Executive Officer | |
| Mafikeng General Hospital | Corporate Officer/Principal | ||
| BAXTER INTERNATIONAL INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
B. Braun Medical, Inc.
 B. Braun Medical, Inc. Medical/Nursing ServicesHealth Services B. Braun Medical, Inc. develops, manufactures, and markets medical products and services. It offers infusion therapy, regional anesthesia and pain management, urinary care, nutrition therapy, renal therapies, ostomy care, and wound management. The company was founded in 1957 and is headquartered in Bethlehem, PA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| Universität zu Lübeck | College/University | Doctorate Degree | |
NB Therapeutics
 NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA. | Pharmaceuticals: Major | Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member | |
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 38 |
| Canadá | 7 |
| Reino Unido | 3 |
| Alemania | 3 |
| India | 2 |
Sectorial
| Health Technology | 26 |
| Consumer Services | 8 |
| Health Services | 4 |
| Commercial Services | 3 |
| Technology Services | 3 |
Operativa
| Director/Board Member | 33 |
| Corporate Officer/Principal | 28 |
| President | 21 |
| Director of Finance/CFO | 18 |
| Chief Executive Officer | 18 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Robert Dickey | 23 |
| Michael Webb | 17 |
| Joseph Tucker | 13 |
| Marcus Schabacker | 12 |
| Paul Medeiros | 10 |
| Avani Kanubaddi | 10 |
| Justin Chakma | 9 |
| Frank Pasqualone | 8 |
| Michael LaCascia | 7 |
| George Kegler | 6 |
| Peter Facchini | 6 |
| Jillian Hagel | 5 |
| Matthew Might | 3 |
| Lynn Gallant | 3 |
- Bolsa de valores
- Insiders
- Kevin Coveney
- Conexiones Empresas
